Autopsy report · NCT00329537
Study of Sargramostim in Moderately to Severely Active Crohn's Disease
Cause of deathNo reason given
Life of this trial
- Ran for about 11 months before it stopped.
- 11 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Genzyme, a Sanofi Company
- Sponsor type
- Industry
- Conditions
- Crohn's Disease
- Interventions
- Sargramostim (Leukine); Placebo
- Participants
- 11
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.